Appili Therapeutics (Appili Therapeutics) Additional Paid-In Capital : $9.59 Mil(As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Appili Therapeutics Additional Paid-In Capital?

Appili Therapeutics's quarterly additional paid-in capital increased from Jun. 2023 ($4.96 Mil) to Sep. 2023 ($9.31 Mil) and increased from Sep. 2023 ($9.31 Mil) to Dec. 2023 ($9.59 Mil).

Appili Therapeutics's annual additional paid-in capital increased from Mar. 2021 ($2.03 Mil) to Mar. 2022 ($3.96 Mil) and increased from Mar. 2022 ($3.96 Mil) to Mar. 2023 ($4.69 Mil).

Appili Therapeutics Additional Paid-In Capital Historical Data

The historical data trend for Appili Therapeutics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Appili Therapeutics Additional Paid-In Capital Chart

Appili Therapeutics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Additional Paid-In Capital

Get a 7-Day Free Trial

0.98

1.30

2.03

3.96

4.69

Appili Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															4.45	4.69	4.96	9.31	9.59

Appili Therapeutics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Appili Therapeutics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Appili Therapeutics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Appili Therapeutics (Appili Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

APLI:Canada

Address

1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8

Website

https://www.appilitherapeutics.com

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.